Ondansetron B. Braun

Ondansetron, the active ingredient in Ondansetron B. Braun, is a 5-HT3 receptor antagonist presented as an intravenous solution for injection use. It treats and helps prevent nausea and vomiting associated with chemotherapy, radiotherapy, and surgery in adult and pediatric patients.

GNH USA supplies Ondansetron B. Braun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ondansetron B. Braun is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting across several clinical pathways. - Chemotherapy‑induced nausea and vomiting: helps reduce the frequency and severity of acute and delayed episodes. - Radiation‑induced nausea and vomiting: provides prophylactic control during radiotherapy. - Post‑operative nausea and vomiting: reduces incidence of nausea and vomiting after surgical procedures. - Pregnancy‑related nausea (hyperemesis gravidarum): used when other treatments are ineffective, under specialist supervision. - Post‑disease ​  ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​  ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​​

Ondond  ​  ​  …  …  ...